Canopy Growth Corp: The Bottom Isn’t In

Canopy Growth Corp (TSX:WEED) is hitting new lows. Unfortunately, the bottom probably isn’t in.

| More on:

Canopy Growth (TSX:WEED) stock has performed extremely badly since cannabis was legalized in October 2018. Almost from that exact date, the stock began a precipitous downfall that continues to this very day. So far this year, WEED stock has declined 59% in value, following several years of similar results. Since the stock hit its peak in October of 2018, it has declined 98% in price! At one point, the stock was well into “penny stock” territory, trading for as little as 50 cents.

Naturally, this got some investors smelling a bargain, as the stock had declined so much that it was beginning to look absurdly cheap. However, as you’ll soon see, Canopy’s valuation is nowhere near as “absurd” as it seems — and it may even be justified. For this reason, I think it’s possible that the bottom in WEED shares isn’t even in. I’ll spend the next few paragraphs explaining why I believe that to be the case.

Revenue declines

One big problem Canopy Growth is having right now is its long-term decline in revenue. Over the last five years, the company’s revenue has declined by about 1.05% per year. This is partially due to underperforming subsidiaries having been sold off, but the problem is the company’s earnings are declining even faster than its revenue is. In that same five-year period, the per-share loss grew from -$0.38 to -$2.45. Therefore, Canopy is having trouble with costs as well as revenue.

Why Canopy Growth is shrinking

There are three main reasons why Canopy Growth Corp is a shrinking business:

  1. Money from the Constellation Brands deal is running out.
  2. Cannabis is a commodity.
  3. Cannabis still faces pressure from the black market.

A few months before legalization hit, Canopy Growth got a $5 billion investment from Constellation Brands. The cash infusion was supposed to be used on growth spending, but as the section above demonstrates, Canopy has shrunk rather than grown. In other words, the cash from STZ is running out, and Canopy has little to show for it.

Second, cannabis is a commodity. Canadian cannabis consumers don’t have very high brand loyalty. Despite the efforts to market different cannabis “strains,” most consumers see them as interchangeable. On top of that, the black market for cannabis still exists and is even thriving in some areas. So, Canopy faces a lot of competition, not just from other cannabis companies but from old-school street dealers as well.

Hope for a better future?

Despite all of the negative things I wrote above, there are some reasons to be optimistic toward Canopy Growth stock. For one thing, all other cannabis companies are in the same boat of declining revenue and large losses. If this situation continues, eventually, some of them will go bankrupt, and the ones left standing will face less competition. The result should be more pricing power and better margins. There’s reason to hope for the sector as a whole, but who knows whether Canopy itself will be the stock to own in a future, more concentrated cannabis industry. Personally, I’m sitting this round out.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Button has no position in any of the stocks mentioned. The Motley Fool recommends Constellation Brands. The Motley Fool has a disclosure policy.

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

Buy the Dip Before It’s Too Late: This Canadian Stock Won’t Stay Cheap Forever

Investors might think that cannabis stocks are out, but this one could be the top Canadian stock to consider.

Read more »

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »